NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY.

NEWS. NATURE Biotechnology. mRNA printers kick-start personalized medicines for all – 09 August 2022

News Published:

mRNA printers kick-start personalized medicines for all

mRNA printers will bring low-cost vaccines and made-to-order treatments for a range of different diseases.

South Africa is setting up mRNA manufacture with new technologies that will ensure vaccines and therapeutics can be made locally and cheaply. Cape Town–based Afrigen joined forces with Belgian firms Univercells and eTheRNA. And the US-based Greenlight Biosciences is about to start a clinical trial of an mRNA vaccine in South Africa, to test a vaccine that will cost about $1 per dose—a fraction of the price of other mRNA vaccines.

Download PDF
2022-11-07T06:41:19+00:00
Go to Top